Whole cohort (a) | DM subgroup (b) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | |||||||||||||
HR | 95.0% CI | P | HR | 95.0% CI | P | HR | 95.0% CI | P | |||||||
Age | 0.86 | 0.59 | – | 1.25 | 0.415 | 0.94 | 0.84 | – | 1.06 | 0.306 | |||||
Sex | 1.94 | 1.14 | – | 3.30 | 0.014* | 1.66 | 0.71 | – | 3.88 | 0.245 | 4.13 | 0.98 | – | 17.44 | 0.054 |
Smoking | 1.34 | 0.91 | – | 1.96 | 0.136 | 0.84 | 0.46 | – | 1.52 | 0.558 | 3.438 | 0.311 | – | 38.06 | 0.314 |
BMI > 24 kg/m2 | 1.1 | 0.75 | – | 1.62 | 0.610 | 1.61 | 0.65 | – | 3.98 | 0.301 | |||||
Hypertension | 0.74 | 0.51 | – | 1.08 | 0.113 | 1.12 | 0.60 | – | 2.06 | 0.726 | 0.67 | 0.25 | – | 1.77 | 0.418 |
Cre > 1.5 mg/dL | 1.03 | 0.60 | – | 1.77 | 0.921 | 1.04 | 0.42 | – | 2.56 | 0.936 | |||||
Dialysis | 0.88 | 0.28 | – | 2.78 | 0.831 | 1.57 | 0.21 | – | 11.7 | 0.658 | |||||
History of other cancers | 0.71 | 0.36 | – | 1.41 | 0.335 | 0.63 | 0.15 | – | 2.69 | 0.536 | |||||
cT1 | 2.14 | 1.47 | – | 3.12 | < 0.001* | 2.05 | 1.06 | – | 3.97 | 0.034* | 1.83 | 0.87 | – | 3.86 | 0.112 |
CIS | 1.58 | 1.03 | – | 2.41 | 0.036* | 0.69 | 0.34 | – | 1.39 | 0.297 | 1.34 | 0.6 | – | 2.96 | 0.476 |
High grade | 1.72 | 1.14 | – | 2.58 | 0.010* | 0.85 | 0.43 | – | 1.68 | 0.643 | 1.45 | 0.61 | – | 3.42 | 0.400 |
Tumor number ≥ 3 | 2.49 | 1.58 | – | 3.94 | < 0.001* | 3.46 | 1.90 | – | 6.33 | < 0.001* | 0.99 | 0.41 | – | 2.41 | 0.982 |
Tumor size ≥3 cm | 1.94 | 1.12 | – | 3.36 | 0.018* | 1.90 | 1.05 | – | 3.42 | 0.033* | 1.94 | 0.64 | – | 5.83 | 0.239 |
Intravesical therapy | 0.97 | 0.36 | – | 2.64 | 0.958 | 21.8 | < 0.01 | – | > 11.00 | 0.790 | |||||
DM | 1.3 | 0.85 | – | 2.00 | 0.229 | 1.11 | 0.57 | – | 2.19 | 0.755 | |||||
Urine sugar ≥100 | 1.86 | 0.87 | – | 3.97 | 0.108 | ||||||||||
HbA1c ≥7 | 3.64 | 1.14 | – | 11.65 | 0.029* | ||||||||||
Metformin | 1.36 | 0.60 | – | 3.10 | 0.460 | ||||||||||
TZD | 0.26 | 0.04 | – | 1.90 | 0.184 |